View more arrow

View more CRI Funded Scientists

Mark A. Sellmyer, MD, PhD

CRI Lloyd J. Old STAR

Dr. Mark A. Sellmyer’s interdisciplinary approach combines molecular imaging with chemical biology to create innovative diagnostic and therapeutic tools. His work includes developing radiotracers for cancer imaging and investigating immune cell dynamics in tumors. Dr. Sellmyer’s research aims to provide critical insights into the mechanisms of immunotherapy and enhance clinical cancer care.

Projects and Grants

Combining Molecular Imaging and Translational Chemical Biology to Improve Cancer Immunotherapies

University of Pennsylvania | All cancers | 2024

Dot decoration
University of Pennsylvania

CRI Funded Scientist

I’m most excited about ways in which imaging and new small molecules can impact our understanding of cancer and improve immunotherapies. CRI’s support is critical for the basic science and discovery arms in our lab, as well as for taking our translational applications to patients.

You Can Help

You can help us make immunotherapy a cancer treatment option for more patients. Together, we can shift the focus from fighting cancer to overcoming cancer.

Donate

Explore More CRI Funded Scientists